Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-17T18:51:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision history now shows an addition of Revision: v3.3.2 and removal of Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-26T08:27:53.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page removed a government funding notice, which is a minor administrative change and does not affect the study record or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-19T08:43:24.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A new version entry was added to the Record History, showing an updated submission date. No core study data appear to be altered.
    Difference
    0.0%
    Check dated 2025-10-28T05:22:27.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    - Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.
    Difference
    7%
    Check dated 2025-10-06T16:28:51.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T10:19:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.